動物疼痛管理の世界市場 (2022-2028年)：薬剤タイプ・動物タイプ・エンドユーザー・投与経路・流通チャネル別の規模・シェア・成長分析・予測

世界の動物疼痛管理の市場規模は、2021年の13億5,000万米ドルから、予測期間中は7%のCAGRで推移し、2028年には21億5,000万米ドルの規模に成長すると予測されています。

ペットの疾病有病率の上昇が同市場の成長を促進しています。Animal Cancer Foundationによると、2018年には米国で6,000万頭以上の犬と3,000万頭以上の猫が末期癌と診断されています。獣医数の増加、先進国における獣医の給与水準の上昇、低コストの処置に対する需要の高まり、動物の健康と福祉に関する意識の高まりなどの要因も予測期間中の市場成長を促進すると考えられています。

当レポートでは、世界の動物疼痛管理の市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。

目次

エグゼクティブサマリー

親市場の分析

• 市場概要
• 市場規模
• 市場力学
• 促進要因
• 機会
• 抑制要因
• 課題
• 主要市場洞察
• 技術分析
• 価格分析
• サプライチェーン分析
• バリューチェーン分析
• 市場のエコシステム
• IP分析
• 貿易分析
• スタートアップ分析
• 原材料分析
• イノベーションマトリックス
• パイプライン製品分析
• マクロ経済指標
• 主要投資分析
• 主な成功要因
• 競合の程度
• 市場力学と展望
• 市場力学
• 促進要因
• 機会
• 抑制要因
• 課題
• 規制状況
• ポーターの分析
• 将来のディスラプションに関するSkyquestの特別な洞察
• 世界の動物疼痛管理市場：薬剤タイプ別
• 市場概要
• オピオイド
• モルヒネ
• ヒドロモルホン
• コデイン
• α2-アドレナリン作動薬
• キシラジン
• メデトミジン
• 局所麻酔薬
• ブピバカイン
• リドカイン
• クロロプロパン
• 非ステロイド系抗炎症薬（NSID）
• エトドラク
• フェンタニル
• メロキシカム
• 鎮静剤
• コルチコステロイド
• その他
• 世界の動物疼痛管理市場：動物タイプ別
• 市場概要
• 家畜
• コンパニオンアニマル
• 世界の動物疼痛管理市場：エンドユーザー別
• 市場概要
• 動物病院薬局
• 小売動物薬局
• オンライン薬局
• 世界の動物疼痛管理市場：投与経路別
• 市場概要
• 経口
• 非経口
• 世界の動物疼痛管理市場：流通チャネル別
• 市場概要
• 動物病院
• 薬局
• 世界の動物疼痛管理市場：地域別
• 市場概要
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ
• 競合情勢
• 主要5社の比較
• 主要企業の市場ポジショニング
• 主要企業の採用戦略
• 主要成功戦略
• 市場における最近の活動
• 主要企業の市場シェア
• 主要企業プロファイル
• Zoetis
• Elanco
• Bayer AG
• Norbrook
• Ceva
• Dechra Pharmaceuticals
• Assisi Animal Health
• Merck Sharp &Dohme Corp
• Boehringer Ingelheim International GmbH
• Virbac
• IDEXX Laboratories
• Vetoquinol
• Evonik Industries AG
• DuPont
• DSM
• Adisseo
• BASF SE
• ADM
• Nutreco
• Novusint
• Cargill Incorporated
• Charoen Pokphand Group
• Sumitomo Chemical
• Kemin Industries, Inc.
• Medtronic

Veterinary Pain Management Market size was valued at USD 1.35 billion in 2021 and is expected to reach USD 2.15 billion by 2028, at a CAGR of 7% during the forecast period (2022-2028).

Veterinary pain management includes diagnostic testing, prevention, and treatment of pain in animals caused by a variety of variables including as vital organ disorders, physical damage, central nervous system and spinal problems, and surgical methods. Practitioners must be able to recognise and relieve pain in a wide range of pet diseases in order to control pain in the veterinary industry. Pain in animals can be caused by a variety of circumstances, including arthritis, cancer, surgical intervention, and so on. Pain can also be connected with aggressive behavior, diminished or complete loss of activity, and other symptoms in animals. Pet and agricultural animal performance can be affected by animal discomfort.

The rising prevalence of pet ailments is driving growth in the Veterinary Pain Management Market. According to the Animal Cancer Foundation, more than 60 million dogs and 30 million cats in the United States were diagnosed with terminal cancer in 2018. The increasing number of veterinary practitioners, as well as rising veterinary practitioner salary levels in developed countries, are two significant drivers driving total expansion. Furthermore, rising demand for low-cost treatment procedures, as well as greater awareness about animal health and welfare, are likely to fuel the growth of the Veterinary Pain Management Market over the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of global Veterinary Pain Management Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Segments covered in this report:

Global veterinary pain management market is segmented based on drug type, animal type, end users, route of administration, distribution channel, region. Based on drug type Veterinary Pain Management Market is segmented into Opioids, Morphine, Hydromorphone, Codeine, α2-adrenergic Agonists, Xylazine, Medetomidine, Local Anaesthetics, Bupivacaine, Lidocaine, Chloropropane, Nonsteroidal Anti-inflammatory Drugs (NSIDs), Etodolac, Fentanyl, Meloxicam, Sedatives, Corticosteroids, Others. Based on animal type Veterinary Pain Management Market is segmented as Livestock animal, Companion animal. Based on end user, the Veterinary Pain Management Market is segmented as Veterinary Hospital pharmacies, Retail Veterinary Pharmacies, Online Pharmacies. Based on route of administration Veterinary Pain Management Market is segmented as Oral Preparations, Parenteral Preparations. Based on distribution channel Veterinary Pain Management Market is segmented as veterinary hospitals, pharmacies. Based on region market is segmented into North America, Asia Pacific, Europe, Latin America and Middle East Africa.

Drivers

Increasing animal welfare funding to drive market growth. The increase in companion animal ownership and big livestock population, the increase in pet insurance with an increase in animal welfare spending, and the increased prevalence of animal diseases are all projected to have an impact on the expansion of the worldwide veterinary pain treatment sector. Furthermore, the rise of the sector is being pushed by an increase in the necessity to preserve animal health and safety in industrialised countries, as well as an increase in global acceptability of pet insurance. Furthermore, the increased prevalence of animal diseases that cause pain and inflammation is moving the sector ahead. Over the projection period, the expanding number of pet owners worldwide is expected to boost industry growth.

Restraint

High R&D expenditures, inadequate infrastructure, uneven distribution of medical services, and a lack of awareness in developing nations are projected to hinder industry expansion. Furthermore, a lack of favourable reimbursement scenarios and technology penetration in developing economies, a decline in advanced-country healthcare expenditures, high costs associated with pet care, and a lack of suitable infrastructure in low- and middle-income countries are expected to pose challenges to the market during the forecast period.

Market Trends

Exploration of undiscovered markets is being expanded in order to offer growth prospects for important companies. In comparison, the growing use of non-traditional and non-pharmaceutical treatment approaches, as well as unexplored new markets, are predicted to provide the industry with future growth potential.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune
• Research Methodology
• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition
• Market Dynamics & Outlook
• Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Regulatory Landscape
• Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Veterinary Pain Management Market by Drug type
• Market Overview
• Opioids
• Morphine
• Hydromorphone
• Codeine
• α2-adrenergic Agonists
• Xylazine
• Medetomidine
• Local Anaesthetics
• Bupivacaine
• Lidocaine
• Chloropropane
• Nonsteroidal Anti-inflammatory Drugs (NSIDs)
• Etodolac
• Fentanyl
• Meloxicam
• Sedatives
• Corticosteroids
• Others
• Global Veterinary Pain Management Market by Animal type
• Market Overview
• Livestock animal
• Companion animal
• Global Veterinary Pain Management Market by End users
• Market Overview
• Veterinary Hospital pharmacies
• Retail Veterinary Pharmacies
• Online Pharmacies
• Global Veterinary Pain Management Market by Route of administration
• Market Overview
• Oral Preparations
• Parenteral Preparations
• Global Veterinary Pain Management Market by Distribution channel
• Market Overview
• Veterinary Hospitals
• Pharmacies
• Global Veterinary Pain Management Market Size by Region
• Market Overview
• North America
• USA
• Canada
• Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
• By Development
• By Company
• By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021
• Key Company Profiles
• Zoetis (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Elanco (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Bayer AG (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Norbrook (UK)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Ceva (France)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Dechra Pharmaceuticals (UK)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Assisi Animal Health (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Merck Sharp & Dohme Corp (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Boehringer Ingelheim International GmbH (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Virbac (France)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• IDEXX Laboratories (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Vetoquinol (France)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Evonik Industries AG (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• DuPont (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• DSM (Netherlands)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Adisseo (China)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• BASF SE (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• ADM (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Nutreco (Netherlands)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Novusint (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Cargill Incorporated (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Charoen Pokphand Group (Thailand)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Sumitomo Chemical (Japan)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Kemin Industries, Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Medtronic (Ireland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments